S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.86 (+0.86%)
AAPL   148.80 (+1.54%)
MSFT   308.59 (+0.42%)
FB   340.08 (+1.41%)
GOOGL   2,865.54 (+0.35%)
TSLA   866.15 (-0.46%)
AMZN   3,442.28 (-0.13%)
NVDA   223.19 (+0.44%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.38 (+8.94%)
GE   104.73 (+0.59%)
AMD   116.26 (-0.15%)
MU   67.66 (+0.59%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.86 (+0.86%)
AAPL   148.80 (+1.54%)
MSFT   308.59 (+0.42%)
FB   340.08 (+1.41%)
GOOGL   2,865.54 (+0.35%)
TSLA   866.15 (-0.46%)
AMZN   3,442.28 (-0.13%)
NVDA   223.19 (+0.44%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.38 (+8.94%)
GE   104.73 (+0.59%)
AMD   116.26 (-0.15%)
MU   67.66 (+0.59%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.86 (+0.86%)
AAPL   148.80 (+1.54%)
MSFT   308.59 (+0.42%)
FB   340.08 (+1.41%)
GOOGL   2,865.54 (+0.35%)
TSLA   866.15 (-0.46%)
AMZN   3,442.28 (-0.13%)
NVDA   223.19 (+0.44%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.38 (+8.94%)
GE   104.73 (+0.59%)
AMD   116.26 (-0.15%)
MU   67.66 (+0.59%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
S&P 500   4,519.63 (+0.74%)
DOW   35,457.31 (+0.56%)
QQQ   375.86 (+0.86%)
AAPL   148.80 (+1.54%)
MSFT   308.59 (+0.42%)
FB   340.08 (+1.41%)
GOOGL   2,865.54 (+0.35%)
TSLA   866.15 (-0.46%)
AMZN   3,442.28 (-0.13%)
NVDA   223.19 (+0.44%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.38 (+8.94%)
GE   104.73 (+0.59%)
AMD   116.26 (-0.15%)
MU   67.66 (+0.59%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:BBH

VanEck Vectors Biotech ETF Stock Forecast, Price & News

$196.45
+1.95 (+1.00 %)
(As of 10/19/2021 03:59 PM ET)
Add
Compare
Today's Range
$196.24
$196.46
50-Day Range
$190.69
$220.01
52-Week Range
$150.52
$222.22
Volume128 shs
Average Volume14,635 shs
Market Capitalization$574.03 million
P/E RatioN/A
Dividend Yield0.31%
Beta0.9
30 days | 90 days | 365 days | Advanced Chart
Receive BBH News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Vectors Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNASDAQ:BBH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Biotech 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$1.92 billion
Average Daily Volume$14,048.50
Discount/Premium-1.27%

ETF Expenses

Management Fee0.35%
Other Expenses0.04%
Total Expenses0.39%
Fee Waiver-0.04%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of BBH

Currency Exposure of BBH

Sector Exposure of BBH

Industry Exposure of BBH













VanEck Vectors Biotech ETF (NASDAQ:BBH) Frequently Asked Questions

What stocks does MarketBeat like better than VanEck Vectors Biotech ETF?

Wall Street analysts have given VanEck Vectors Biotech ETF a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but VanEck Vectors Biotech ETF wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has VanEck Vectors Biotech ETF's stock price been impacted by Coronavirus?

VanEck Vectors Biotech ETF's stock was trading at $126.82 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BBH stock has increased by 53.4% and is now trading at $194.50.
View which stocks have been most impacted by COVID-19
.

How often does VanEck Vectors Biotech ETF pay dividends? What is the dividend yield for VanEck Vectors Biotech ETF?

VanEck Vectors Biotech ETF announced an annual dividend on Friday, December 18th. Investors of record on Tuesday, December 22nd will be given a dividend of $0.608 per share on Monday, December 28th. This represents a yield of 0.35%. The ex-dividend date of this dividend is Monday, December 21st. This is an increase from VanEck Vectors Biotech ETF's previous annual dividend of $0.42.
View VanEck Vectors Biotech ETF's dividend history
.

Is VanEck Vectors Biotech ETF a good dividend stock?

VanEck Vectors Biotech ETF pays an annual dividend of $0.61 per share and currently has a dividend yield of 0.31%.
View VanEck Vectors Biotech ETF's dividend history.

What other stocks do shareholders of VanEck Vectors Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Biotech ETF investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), (SNY), Intel (INTC), Micron Technology (MU), Cidara Therapeutics (CDTX), Quest Diagnostics (DGX), (MRNA) and Novavax (NVAX).

What is VanEck Vectors Biotech ETF's stock symbol?

VanEck Vectors Biotech ETF trades on the NASDAQ under the ticker symbol "BBH."

Who are VanEck Vectors Biotech ETF's major shareholders?

VanEck Vectors Biotech ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Private Advisor Group LLC (0.07%).

Which institutional investors are selling VanEck Vectors Biotech ETF stock?

BBH stock was sold by a variety of institutional investors in the last quarter, including Private Advisor Group LLC.

How do I buy shares of VanEck Vectors Biotech ETF?

Shares of BBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is VanEck Vectors Biotech ETF's stock price today?

One share of BBH stock can currently be purchased for approximately $194.50.

How much money does VanEck Vectors Biotech ETF make?

VanEck Vectors Biotech ETF has a market capitalization of $568.33 million.


This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.